Status:
TERMINATED
Bronchial Asthma and Diabetes: Impact on Bronchial Inflammation and Exercise Capacity
Lead Sponsor:
Istituti Clinici Scientifici Maugeri SpA
Collaborating Sponsors:
Galmarini Hospital, Tradate
Conditions:
Asthma
Diabete Type 2
Eligibility:
All Genders
18-85 years
Brief Summary
Type 2 diabetes is the most common form of diabetes and according to several studies, even lung can represent another target of the diabetic disease. Asthmatic patients often show comorbidities and ob...
Detailed Description
The basic therapy for asthma treatment involves the use of corticosteroids that can lead to the development of glucose intolerance and to the onset of diabetes. Moreover, several works in literature h...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Diagnosis of bronchial asthma according to the GINA 2018 guideline
- Clinical stability of asthmatic disease
- Diagnosis of Type II diabetes according to the last Italian guidelines (1) and HbA1c \< 9%, 54-75mmol/mol
- Concomitant diagnosis of bronchial asthma (12) and diabetes according to the described guidelines
- Age ≥18 years
- Not-smokers, smokers or ex-smokers with pack/year ≤10
- Patients able to collaborate in the required procedures and who have signed the informed consent
- Exclusion criteria:
- Bronchial asthma and/or diabetes with scarce clinical control.
- Diagnosis of cognitive impairment
- Not able to carry out study procedures
Exclusion
Key Trial Info
Start Date :
July 10 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 12 2024
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT04448262
Start Date
July 10 2019
End Date
January 12 2024
Last Update
February 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istituti Clinici Maugeri Pneumologia
Tradate, Lombardy, Italy, 21049